Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer

Clinical trial NCT01205217 · WITHDRAWN

Trial details

NCT number: NCT01205217
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2010-12-01
Primary completion: 2010-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.